Binding Site Information of Target
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T29130 | Target Info | |||
Target Name | Signal transducer and activator of transcription 3 (STAT3) | ||||
Synonyms | Acute-phase response factor; APRF | ||||
Target Type | Successful Target | ||||
Gene Name | STAT3 | ||||
Biochemical Class | Transcription factor | ||||
UniProt ID |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
Ligand Name: 5'-iodotubercidin | Ligand Info | |||||
Structure Description | Crystal structure of ERK2 complexed with allosteric and ATP-competitive inhibitors. | PDB:5AX3 | ||||
Method | X-ray diffraction | Resolution | 2.98 Å | Mutation | No | [1] |
PDB Sequence |
LVKKYILALW
358 NE
|
|||||
|
||||||
Ligand Name: ((2-(((5S,8S,10aR)-3-acetyl-8-(((S)-5-amino-1-(benzhydrylamino)-1,5-dioxopentan-2-yl)carbamoyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocin-5-yl)carbamoyl)-1H-indol-5-yl)difluoromethyl)phosphonic acid | Ligand Info | |||||
Structure Description | Stat3 Core in complex with compound SD36 | PDB:6NJS | ||||
Method | X-ray diffraction | Resolution | 2.70 Å | Mutation | No | [2] |
PDB Sequence |
VVTEKQQMLE
145 QHLQDVRKRV155 QDLEQKMKVV165 ENLQDDFDFN175 YKTLKNQSVT196 RQKMQQLEQM 206 LTALDQMRRS216 IVSELAGLLS226 AMEYVQKTLT236 DEELADWKRR246 QQIACIGGPP 256 NICLDRLENW266 ITSLAESQLQ276 TRQQIKKLEE286 LQQKVSYKGD296 PIVQHRPMLE 306 ERIVELFRNL316 MKSAFVVERQ326 PCMPMHPDRP336 LVIKTGVQFT346 TKVRLLVKFP 356 ELNYQLKIKV366 CIDKDRGSRK383 FNILGTNTKV393 MNMEESNNGS403 LSAEFKHLTL 413 REQRCLIVTE434 ELHLITFETE444 VYHQGLKIDL454 ETHSLPVVVI464 SNICQMPNAW 474 ASILWYNMLT484 NNPKNVNFFT494 KPPIGTWDQV504 AEVLSWQFSS514 TTKRGLSIEQ 524 LTTLAEKLLG534 PGVNYSGCQI544 TWAKFCKENM554 AGKGFSFWVW564 LDNIIDLVKK 574 YILALWNEGY584 IMGFISKERE594 RAILSTKPPG604 TFLLRFSESS614 KEGGVTFTWV 624 EKDISGKTQI634 QSVEPYTKQQ644 LNNMSFAEII654 MGYKIMDATN664 ILVSPLVYLY 674 PDIPKEEAFG684 KYC
|
|||||
|
ARG609
2.799
PHE610
4.693
SER611
2.690
GLU612
2.821
SER613
2.701
SER614
4.384
THR620
3.619
TRP623
4.079
GLN635
3.903
SER636
2.790
|
|||||
Click to View More Binding Site Information of This Target and Ligand Pair |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Identification of allosteric ERK2 inhibitors through in silico biased screening and competitive binding assay. Bioorg Med Chem Lett. 2016 Feb 1;26(3):955-958. | ||||
REF 2 | A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In?Vivo. Cancer Cell. 2019 Nov 11;36(5):498-511.e17. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.